English中文

What is Liquid Biopsy?  


    Cancer detection and monitoring method


    Liquid Biopsy, also known as fluid biopsy, is a significant branch of in vitro diagnosis that is primarily based on blood or other body fluid for disease analysis and monitoring, such as cancer. With a simple blood draw, circulating tumor biomarkers in the blood sample provide information on tumor progression and treatment efficacy, and guiding personalized precision medication direction. Compared with traditional tissue biopsy, liquid biopsy has provided additional benefits of real-time monitoring, avoid unrepresentative sampling in heterogenous tumor, and provides comprehensive clinical information.


    Liquid Biopsy is a branch of in vitro diagnostics that analyses and diagnoses diseases such as cancer through the use of body liquids like blood or urine. It was rated as one of the “Breakthrough Technologies 2015” by MIT Technology Review.


    Compared to traditional tissue biopsy, liquid biopsy is equipped with unique advantages like real-time monitoring, ability to overcome tumor heterogeneity, and comprehensive diagnostic information. Currently, in clinical researches, liquid biosy mainly includes tests for CTC (Circulating Tumor Cell), ctDNA (Circulating Tumor DNA), exosomes, and Circulating miRNA etc. In comparison to traditional methods like observation of clinical symptoms or diagnostic imaging, using liquid biopsy can predict the risk of cancer earlier, enabling “Early discovery, early screening, early treatment”.


What is Circulating miRNA?


microRNAs or miRNAs are small RNA molecules that are non-coding and have important effects on gene expression, often inhibitory.  By binding to mRNAs in the cells, the microRNAs inhibit DNA functioning, thus affecting important life functions in a cell. In many cancer types, miRNAs production is upregulated, converting an ordinary cell into a cancerous one. Additionally, these miRNAs can be transported outside the cell, in the tumour environment, in sacs/vesicles called 'exosomes'. The presence of a high number of exosomal miRNAs has been associated with the spread of certain types of cancer in the body. Isolation and detection of miRNAs from a patient’s blood can help in early cancer diagnosis, without the need for invasive surgeries.

What is Circulating Tumor Cell (CTC)?


Circulating tumor cell (CTCs) are the cancer cells that have detached from the primary tumor or metastatic tumor into circulatory system during tumor progression or metastases. CTC provides comprehensive information of cancer in cellular, genetics and protein levels. Hence, CTC detection is an effective tool for earlier detection, evaluation of therapeutic efficacy, individual precision medicine selection, drug resistance detection, earlier tumor recurrence evaluation and real-time monitoring of cancer.


How can we detect CTCs in blood?


Cellomics CTC detection Platform - New generation of CTC viable Cell Sorting.


The CTC detection platform has employed the leading microfluidic chip technology that select CTCs extensively by cell size, cell shape and multiple surface biomarkers. This technology has combined the physical, chemical and biological properties of CTCs to uphold the high sensitivity, high specificity and high accuracy of CTC detection.


图片展示

COVID-19 2020 PANDEMIC

 

With the number of Covid-19 cases increasing every day and nearing 28 million worldwide, nations across the world are still struggling to test their citizens with a few countries far away from attaining the disease peak. 

 

CURRENT PAINPOINTS OF COVID-19 DETECTION METHODS

图片展示
  • Take a few hours to a couple of days to give back results

  • The process is time consuming, tedious, and potentially delay emergency treatment in some critical cases. 

图片展示
  • transportation of samples to certified clinical laboratories

  • Improper handling may lead to contamination

  • Large Laboratory apparatuses are required 

图片展示
  • require proper professionals to conduct the tests

  • Improper handling may lead to contamination

  • Potentially poses harm or infection to operators

CovFreeTM:
Secure and control the spread

by rapid and portable

COVID-19 device

üPortable

üUser-friendly 

üFast results 

üSensitive 

üQuantitative measurement

üClosed device

üSecure 

üWidespread use



There is a need for a far-reaching solution that delivers results within a short span, having high sensitivity and the ease of being operated by lay people. A solution that allows citizens to gather at events without any hesitation of potential threats so that life can resume back to normal and people can live FREELY again.

TOGETHER WITH US, LET’S CREATE FAST, RAPID, EFFICIENT, EASY AND LOW-COST CovFreeTM TO MAKE THE WORLD YES AGAIN!

图片展示

Product 

CTC 100 Sorter

CTC PreDX

CTCMntDX

CTCImmunoDx

About 

The Team

Awards

News

Blog

Contact Us

Email: info@cellomicsbio.com

Tel: +86-0755-28378001

Copyright © 2020 Cellomics All Rights Reserved

Copyright © 2020 Cellomics All Rights Reserved

添加微信好友,详细了解产品
使用企业微信
“扫一扫”加入群聊
复制成功
添加微信好友,详细了解产品
我知道了